Pillstats
Rx only · Capsule, Liquid Filled · Oral

Calcitriol

Calcitriol

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA11CC04
RxCUI (US)1894
US makers7 labelers
Packages28
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.057$0.115$0.172$0.229Dec 2025Apr 2026Jul 2026
$0.193
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
6
Active US suppliers
65%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

17K33K50K66K2025 Q12025 Q22025 Q32025 Q42026 Q1
48K
Rx · 2026 Q1
2.3M
Units dispensed
-17%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager11SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown6SUPPLYING
Bionpharma Inc.unknown4SUPPLYING
Golden State Medical Supply, Inc.unknown2SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown2SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown2EXITED 2027

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 4, 2025
    RESOLVEDShortage resolved: Calcitriol Capsule (Teva Pharmaceuticals USA, Inc.)

    Calcitriol Capsule — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Endocrinology/Metabolism.

  • Dec 4, 2025
    SHORTAGEDrug shortage: Calcitriol Capsule (Teva Pharmaceuticals USA, Inc.)

    Calcitriol Capsule — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Endocrinology/Metabolism.